April 25, 2024
Oxford, UK – Oxford Nanopore Technologies (Oxford Nanopore) today announced the launch of its Compatible Products Programme, a new initiative designed to establish and showcase approved compatible third-party products, ensuring seamless use in combination with Oxford Nanopore’s sequencing products. The programme will expand the network of products compatible with Oxford Nanopore’s platform to enhance the overall [...]
Merck Invests More Than € 300 Million in New Life Science Research Center in Germany
April 25, 2024
German Chancellor Olaf Scholz emphasizes significance for Germany as research location at cornerstone laying ceremony Research center to accelerate biopharmaceutical product development Part of Merck’s € 1.5 billion investment program in Darmstadt by 2025 DARMSTADT, GERMANY -- Merck, a leading science and technology company, is investing more than € 300 million in a new research [...]
BioBased 96-well PCR Plates – Now also semi-skirted
April 25, 2024
Hamburg -- Our customers depend on the high performance and reliability of the plates used in their high-throughput processes. However, increased throughput results in a higher carbon footprint due to the use of single-use plates made from fossil-based plastics. There is now a growing demand for more sustainability. Eppendorf’s biobased consumables open up new doors to [...]
Standard BioTools Announces Operational Restructuring Plan to Drive Long-Term Profitable Growth
April 25, 2024
Company expects to achieve $45-$50 million in annualized operating expense savings in fiscal 2025 Management to discuss first quarter 2024 financial results, restructuring and strategic initiatives on May 8, 2024 conference call SOUTH SAN FRANCISCO, Calif. -- Standard BioTools Inc. (“Standard BioTools” or the “Company”) (Nasdaq: LAB) today announced that it has initiated a restructuring plan to improve operational efficiency [...]
Revvity Unveils a New Era of Automated Tuberculosis Testing
April 24, 2024
New and improved workflow now available that pairs Revvity’s T-SPOT™.TB test with the Auto-Pure 2400 liquid handling platform Substantially lowers hands-on time, allowing for increased lab productivity WALTHAM, Mass. -- Revvity, Inc. (NYSE: RVTY) today announced the launch of the Auto-Pure 2400 liquid handler from Allsheng for use with the T-SPOT.TB test. The Auto-Pure 2400 platform is [...]
April 24, 2024
Launch of QIAseq xHYB Mycobacterium tuberculosis Panel for research use, enabling culture-free whole genome sequencing from complex samples Panel significantly accelerates TB outbreak tracking and supports detection and management of antimicrobial resistance, critical needs in TB surveillance and control Building upon success of leading diagnostics test QuantiFERON-TB Gold Plus as QIAGEN extends portfolio for TB [...]
April 24, 2024
SINGAPORE -- GenScript, a global leader in life sciences and biotechnology, successfully hosted an Open Day event at its Singapore facility on the 16th of April, welcoming more than 50 representatives from Singapore. This event provided an exclusive look into GenScript's state-of-the-art gene and protein production facility, particularly highlighting the company's advancements in AI-driven gene [...]
Lexogen introduces new RiboCop rRNA Depletion Kit for Plants
April 24, 2024
Vienna, Austria – Lexogen, a leading company in transcriptomics and Next-Generation Sequencing (NGS) announces the release of RiboCop rRNA Depletion for Plants, a solution that efficiently removes unwanted ribosomal RNA (rRNA) from various plant samples, including roots, seeds, and leaves from different plant species. RiboCop for Plants integrates seamlessly into end-to-end RNA-Seq workflows, enabling researchers to understand plant [...]
April 24, 2024
Program will support faster insights for large-scale studies and drug development SEATTLE – Parse Biosciences, a leading provider of accessible and scalable single cell sequencing solutions, today announced it has launched its Laboratory Automation Provider Program, enabling automation providers to readily support the adoption of Parse’s Evercode™ single cell products. By combining powerful automation with the [...]
Genomics Luminary and former Illumina Executive Bob Kain Joins Single Technologies as an Advisor
April 23, 2024
Stockholm, Sweden – Renowned genomics pioneer, Bob Kain, has joined Single Technologies as an advisor to support the commercialization of their 3-D DNA sequencing system. Kain is perhaps most famous for his work at Illumina from 1999 to 2014. During this time, he not only helped the company grow from a 30-employee start-up into a [...]

